Cancer cells can alter translation through various mechanisms. These include upregulation of translation initiation factors, increased expression of ribosomal proteins, and mutations in translation-related genes. Additionally, cancer cells often exhibit increased activity of signaling pathways, such as the PI3K/AKT/mTOR pathway, that enhance translation.
